Preoperative assessment of asymptomatic adnexal masses by positron emission tomography and F-18-Fluorodeoxyglucose;Praoperative dignitatsbeurteilung asymptomatischer adnextumoren mittels positronen-emissions-tomographie und F-18-Fluordeoxyglukose

NuklearMedizin

Volumn 38, Issue 4, 1999, Pages 101-107

  Fenchel, Sabine ^a   Kotzerke, J ^b   Stohr I ^b   Grab, D ^b   Nussle K ^b   Rieber, A ^b   Kreienberg, R ^b   Brambs, H J ^b   Reske, S N ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Borderline tumors; F 18 FDG; Ovarian tumors; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADNEXA DISEASE; ADULT; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; TUMOR DIAGNOSIS; ADOLESCENT; AGED; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY TUMOR; PATHOLOGY; PROSPECTIVE STUDY; SCINTISCANNING; SWEAT GLAND TUMOR;

ADOLESCENT; ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, ADNEXAL AND SKIN APPENDAGE; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032601490     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632200     Document Type: Article

References (22)

1. Bender H, Schomburg A, Ruhlmann J, Biersack HJ. Possible role of FDG-PET in the evaluation of urologie malignancies. Anti-cancer Res 1997; 17: 1655-60.
2. Bischof-Delaloye A, Wahl R. How high a level of FDG abdominal activity is considered normal? (abstract). J Nucl Med 1995; 36: 106p.
3. Bragg DG, Hricak H. Imaging in gynecologic malignancies. Cancer 1993; 71: 1648-51.
4. Casey MJ, Gupta NC, Muths CK. Experience with positron emission tomography (PET) scans in patients with ovarian cancer. Gynecol Oncol 1994; 53: 331-8.
5. 18F-FDG). Gynecol Oncol 1993; 51: 197-204.
6. Karlan BY, Hawkins R, Hoh K, Lee M, Tse N, Cane P, Glaspy J. Whole-body positron emission tomography with 2-F-18-Fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma. Gynecol Oncol 1993; 51: 175-81.
7. Knight SB, Delbeke D, Stewart JR, Sandler MP. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 1996; 109: 982-8.
8. Kubota R, Kubota K, Yamada S, Tada M, Takahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-80.
9. Kubota K, Yamada S, Kondo T, Yamada K, Fukuda H, Fujiwara T, Ito M, Ido T. PET imaging of primary mediastinal tumors. Br J Cancer 1996; 73: 882-6.
10. Magrina JF, Cornella JL. Concise review for primary care physicians. Mayo Clin Proc 1997; 72: 653-6.
11. Minelli L. Ovarian cysts. Eur J Obstet Gynecol Reprod Biol 1996; 65: 81-9.
12. Osmers R. Sonographic evaluation of ovarian mass and its therapeutical implications. Ultrasound Obstet Gynecol 1996; 8: 217-22.
13. Osmers RGW, Osmers M, Maydell von B, Wagner B, Kuhn W. Preoperative evaluation of ovarian tumors in the premenopause by transvaginosonography. Am J Obstet Gynecol 1996; 175: 428-34.
14. Reinhard MJ, Muller-Mattheis VG, Gerharz CD, Vosberg HR, Ackermann R, Muller-Gartner HWT. FDG-PET evaluation of retroperitoneal metastases of testicular cancer before and after chemotherapy. J Nucl Med 1997; 38: 99-101.
15. Reske SN, Bares R, Büll U, Guhlmann A, Moser E, Wannenmacher MF. Klinische Wertigkeit der Positronen-Emissions-Tomography (PET) bei onkologischen Fragestellungen: Ergebnisse einer interdisziplinären Konsensuskonferenz. Nuklearmedizin 1996; 35: 42-52.
16. Römer W, Avril N, Dose J, Ziegler S, Kuhn W, Herz M, Jänicke F, Schwaiger M. Metabolische Charakterisierung von Ovarialtumoren mit der Positronen-Emissions-Tomographie und F-18-Fluordeoxyglucose. Fortschr Röntgenstr 1997; 166: 62-8.
17. Schmidlin P, Doll J. Implementation of iterative reconstruction in positron emission tomography. Prog Clin Biol Res 1991; 363: 59-67.
18. Stephens AW, Gonin R, Hutchins GD, Einhorn LH. Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients. J Clin Oncol 1996; 14: 1637-41.
19. Tanos V, Schenker JG. Ovarian cysts: a clinical dilemma. Gynecol Endocrinol 1994; 8: 59-67.
20. Wilson CB, Young HE, Olt RJ, Flower MA, Cronin BF, Pratt BE, McCready VR, Horwich A. Imaging metastatic testicular germ cell tumors with F-18-FDG positron emission tomography. Eur J Nucl Med 1995; 22: 508-13.
21. Yancik R. Qvarian cancer, age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer Suppl 1992; 71: 518-23.
22. Zimny M, Schröder W, Wolters S, Cremerius U, Rath W, Büll U. F-18-Fluordeoxyglucose PET beim Ovarialkarzinom: Methodik und erste Ergebnisse. Nuklearmedizin 1997; 16: 118-223.